Results 91 to 100 of about 760 (154)

Microbiological eradication of XDR <i>Acinetobacter baumannii</i> intra-abdominal infection using sulbactam-durobactam: clinical and microbiological outcomes amidst irreversible host comorbidities. [PDF]

Front Med (Lausanne)
Yu L, He J, Chan W, Zou S, Zhou Q, Jin J.   +5 more
europepmc   +1 more source

Successful treatment of carbapenem-resistant <i>Acinetobacter baumannii</i> and Enterobacterales coinfection with sulbactam-durlobactam combined with aztreonam: a case report. [PDF]

AME Case Rep
Yang S, Cheng Z, Liu Y, Ni L, Wei C.
europepmc   +1 more source

Clinico-Microbiological Profile of Carbapenem-Resistant Acinetobacter baumannii Isolates From Intensive Care Unit Patients and In Vitro Activity of Sulbactam-Durlobactam: A Cross-Sectional Study From Eastern India. [PDF]

Cureus
Susanna A, Singh N, Verma G, Mohapatra I, Pradhan S, Panda SS, Prince B, Pattnaik D, Mishra PP.   +8 more
europepmc   +1 more source

Successful Treatment with Sulbactam-Durlobactam for Severe Acute Pancreatitis Complicated by Extensively Drug-Resistant <i>Acinetobacter baumannii</i> Infection at Multiple Sites: A Case Report. [PDF]

Infect Drug Resist
Ge Z, Li L, Wang L, Liu D, Liu Y.
europepmc   +1 more source

Systematic and quantitative analyses of hollow fiber model of <i>Mycobacterium abscessus</i> lung disease studies and new dosing recommendations. [PDF]

Microbiol Spectr
Srivastava S, Gumbo T.
europepmc   +1 more source

Sulbactam-Durlobactam in the Treatment of Bloodstream Infection Due to Carbapenem-Resistant <i>Acinetobacter baumannii</i>: A Case Series and Literature Review. [PDF]

J Clin Med
Li R, Duan L, Sun S, Li D, Peng Q, Shang Y.   +5 more
europepmc   +1 more source

Successful Use of Sulbactam-Durlobactam in Treating Carbapenem-Resistant Acinetobacter baumannii Pneumonia and Sepsis After Liver Transplantation: A Case Report. [PDF]

Am J Case Rep
Xiong HF, Zhang WT, Liu Y, Hou F, Liu B, Cui TT, He ZY, Zhang X, Zhao R, Sun LY.   +9 more
europepmc   +1 more source

Therapeutic challenges and emerging strategies against carbapenem-resistant <i>Acinetobacter baumannii</i>. [PDF]

Curr Res Microb Sci
Yang C, Li J, Luo X, Song Z, Zhang J.
europepmc   +1 more source

Carbapenem-resistant <i>Acinetobacter</i> (CRAB) and outpatient antibiotic therapy (OPAT): between a rock and hard place. [PDF]

JAC Antimicrob Resist
White BP, Siegrist EA.
europepmc   +1 more source

<i>In vitro</i> evolution of durlobactam resistance in NDM-producing <i>Escherichia coli</i> due to a single mutation in <i>mrdA</i> encoding penicillin-binding protein 2. [PDF]

Antimicrob Agents Chemother
McElheny CL, Butcher EL, Kawai A, Shanks RMQ, Shields RK, Doi Y.   +5 more
europepmc   +1 more source